MARKET

CRBP

CRBP

Corbus Pharmaceu
NASDAQ
37.74
+0.04
+0.11%
After Hours: 37.74 0 0.00% 16:00 04/23 EDT
OPEN
37.83
PREV CLOSE
37.70
HIGH
40.08
LOW
37.51
VOLUME
500.52K
TURNOVER
0
52 WEEK HIGH
49.87
52 WEEK LOW
3.033
MARKET CAP
396.54M
P/E (TTM)
-3.6617
1D
5D
1M
3M
1Y
5Y
Cannabis Stock Movers For April 22, 2024
Affinor Growers shares closed up 80.31% at $0.11. Green Growth Brands (OTC:GGBXF) shares closed down 90.00%. The company's stock is down more than 90% from its recent high. The shares of Elixinol Wellness and Rocky Mountain High also closed up.
Benzinga · 1d ago
Weekly Report: what happened at CRBP last week (0415-0419)?
Weekly Report · 2d ago
Cannabis Stock Movers For April 19, 2024
Global Compliance shares closed up 72.62% at $0.01. Affinor Growers and Body and Mind are among the company's gainers. 1933 Industries shares closed down 26.67% in the last day of trading. The company's shares are down 5.95% in a day.
Benzinga · 4d ago
Neutral On Corbus Pharmaceuticals' Financials And Clinical Progress In Oncology
Seeking Alpha · 4d ago
Marijuana Stock Movers For April 17, 2024
Green Growth Brands (OTC:GGBXF) shares closed up 900.00% at $1e-05. Elixinol Wellness, shares up 48.15%. Khiron Life Sciences shares closed down 99.99%. Shares of Aurora Cannabis closed down 3.39%.
Benzinga · 6d ago
Cannabis Stock Gainers And Losers From April 16, 2024
Global Hemp Group shares closed up 66.67% at $0.05. Heritage Cannabis Holding shares up 28.57%. Item 9 Labs shares closed down 33.33%. Aurora Cannabis shares down 6.85% in the last day of trading. The company's shares closed at $4.99.
Benzinga · 04/16 20:30
Weekly Report: what happened at CRBP last week (0408-0412)?
Weekly Report · 04/15 10:41
Marijuana Stock Movers For April 11, 2024
Global Hemp Group (OTC:GBHPF) shares closed up 22.00% at $0.05. Target Group shares closed down 20.87% in the last trading day. Belgravia Hartford Cap shares closed 31.24% up. Shares of Item 9 Labs closed up 27.12%.
Benzinga · 04/11 20:30
More
About CRBP
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.

Webull offers Corbus Pharmaceuticals Holdings Inc stock information, including NASDAQ: CRBP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRBP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRBP stock methods without spending real money on the virtual paper trading platform.